Inhaltsbereich
| 197 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 › » |
Seite 1 / 10
 Druckansicht
|
| Activity of T-DM1 in Her2-positive breast cancer brain metastases. |
| Bartsch R, Berghoff AS, Vogl U, Rudas M, Bergen E, Dubsky P, Dieckmann K, Pinker K, Bago-Horvath Z, Galid A, Oehler L, Zielinski CC, Gnant M, Steger GG, Preusser M |
| Clinical & experimental metastasis. 2015 Aug 25. doi: 10.1007/s10585-015-9740-3 |
| PMID: 26303828 |
| Bevacizumab: no comeback in early breast cancer? |
| Bartsch R, Gnant M, Steger GG |
| The Lancet. Oncology. 2015 Aug 10. pii: S1470-2045(15)00124-2. doi: 10.1016/S1470-2045(15)00124-2 |
| PMID: 26272771 |
| Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy. |
| Promberger R, Dubsky P, Mittlböck M, Ott J, Singer C, Seemann R, Exner R, Panhofer P, Steger G, Bergen E, Gnant M, Jakesz R, Bago-Horvath Z, Rudas M, Bartsch R |
| Clinical breast cancer. 2015 Jun 18. pii: S1526-8209(15)00123-8. doi: 10.1016/j.clbc.2015.06.007 |
| PMID: 26195436 |
| Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. |
| Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF |
| Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3 |
| PMID: 26040499 |
| The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial. |
| Fitzal F, Filipits M, Rudas M, Greil R, Dietze O, Samonigg H, Lax S, Herz W, Dubsky P, Bartsch R, Kronenwett R, Gnant M |
| British journal of cancer. 2015 Mar 24. pii: bjc201598. doi: 10.1038/bjc.2015.98. pmc: PMC4402462 |
| PMID: 25867274 |
| Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal. |
| Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C, Zografos GC, Dimopoulos MA, Azim HA |
| Breast (Edinburgh, Scotland). 2015 Mar 25. pii: S0960-9776(15)00057-0. doi: 10.1016/j.breast.2015.02.031 |
| PMID: 25818651 |
| Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer. |
| Bergen E, Berghoff AS, Rudas M, Dubsky P, De Vries C, Sattlberger C, Mader RM, Zagouri F, Sparber C, Fitzal F, Gnant M, Rottenfusser A, Zielinski CC, Preusser M, Steger GG, Bartsch R |
| Breast care (Basel, Switzerland). 2015 Mar 11. doi: 10.1159/000368330. pii: brc-0009-0344. pmc: PMC4322687 |
| PMID: 25759615 |
| Breast cancer brain metastases responding to lapatinib plus capecitabine as second-line primary systemic therapy. |
| Bergen ES, Berghoff AS, Rudas M, Preusser M, Bartsch R |
| Anti-cancer drugs. 2015 Apr 2. doi: 10.1097/CAD.0000000000000217 |
| PMID: 25714248 |
| CDK4/6 inhibitors in luminal breast cancer. |
| Gnant M, Steger GG, Bartsch R |
| The Lancet. Oncology. 2014 Dec 16. pii: S1470-2045(14)71188-X. doi: 10.1016/S1470-2045(14)71188-X |
| PMID: 25524801 |
| Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy. |
| Haslik W, Hacker S, Felberbauer FX, Thallinger C, Bartsch R, Kornauth C, Deutschmann C, Mader RM |
| European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014 Dec 4. pii: S0748-7983(14)01262-1. doi: 10.1016/j.ejso.2014.11.042 |
| PMID: 25515823 |
| Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol. |
| Pluschnig U, Haslik W, Bayer G, Soleiman A, Bartsch R, Lamm W, Steger GG, Zielinski CC, Mader RM |
| Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2014 Nov 30. doi: 10.1007/s00520-014-2535-2 |
| PMID: 25433440 |
| Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12. |
| Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Knauer M, Moik M, Jakesz R, Seifert M, Taucher S, Bjelic-Radisic V, Balic M, Eidtmann H, Eiermann W, Steger G, Kwasny W, Dubsky P, Selim U, Fitzal F, Hochreiner G, Wette V, Sevelda P, Ploner F, Bartsch R, Fesl C, Greil R |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Nov 17. pii: mdu544. doi: 10.1093/annonc/mdu544 |
| PMID: 25403582 |
| Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases. |
| Berghoff AS, Ricken G, Widhalm G, Rajky O, Dieckmann K, Birner P, Bartsch R, Höller C, Preusser M |
| Histopathology. 2014 Nov 10. doi: 10.1111/his.12537 |
| PMID: 25314639 |
| Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues. |
| Berghoff AS, Bartsch R, Wöhrer A, Streubel B, Birner P, Kros JM, Brastianos PK, von Deimling A, Preusser M |
| Acta neuropathologica. 2014 Oct 7. doi: 10.1007/s00401-014-1350-7 |
| PMID: 25287912 |
| Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases. |
| Berghoff AS, Ilhan-Mutlu A, Dinhof C, Magerle M, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Pichler J, Hutterer M, Melchardt T, Bartsch R, Zielinski CC, Birner P, Preusser M |
| Neuropathology and applied neurobiology. 2015 Jan 29. doi: 10.1111/nan.12185 |
| PMID: 25256708 |
| αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer. |
| Berghoff AS, Kovanda AK, Melchardt T, Bartsch R, Hainfellner JA, Sipos B, Schittenhelm J, Zielinski CC, Widhalm G, Dieckmann K, Weller M, Goodman SL, Birner P, Preusser M |
| Clinical & experimental metastasis. 2014 Aug 24. doi: 10.1007/s10585-014-9675-0 |
| PMID: 25150423 |
| Indocyanine green video angiography predicts outcome of extravasation injuries. |
| Haslik W, Pluschnig U, Steger GG, Zielinski CC, Schrögendorfer KF, Nedomansky J, Bartsch R, Mader RM |
| PloS one. 2014 Aug 21. doi: 10.1371/journal.pone.0103649. pii: PONE-D-14-14898. pmc: PMC4140719 |
| PMID: 25144707 |
| Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients. |
| Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P |
| Breast (Edinburgh, Scotland). 2014 Jul 10. pii: S0960-9776(14)00124-6. doi: 10.1016/j.breast.2014.06.011 |
| PMID: 25017122 |
| The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer. |
| Exner R, Bago-Horvath Z, Bartsch R, Mittlboeck M, Retèl VP, Fitzal F, Rudas M, Singer C, Pfeiler G, Gnant M, Jakesz R, Dubsky P |
| British journal of cancer. 2014 Jul 8. pii: bjc2014339. doi: 10.1038/bjc.2014.339. pmc: PMC4150264 |
| PMID: 25003667 |
| Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study. |
| Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Jul 2. pii: 1078-0432.CCR-13-2810. doi: 10.1158/1078-0432.CCR-13-2810 |
| PMID: 24963052 |
| 197 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 › » |
Seite 1 / 10
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
